Nathan H. Walcker

Nathan H. Walcker is a seasoned executive with extensive experience in the healthcare sector. Currently serving as Chief Executive Officer and Chief Financial Officer at Florida Cancer Specialists & Research Institute since 2019, Nathan also holds the position of Health Evolution Senior Fellow at Health Evolution since 2022. Previously, Nathan was Chief Financial Officer at American Oncology Network, LLC from 2019 to 2020 and spent a decade at Bank of America Merrill Lynch as a healthcare investment banker, specializing in M&A advisory for healthcare services and tech-enabled services. Nathan holds an MBA in Finance from Columbia Business School and a BA in Economics from Columbia University.